US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Latigo Biotherapeutics Inc

16.70

-1.4000-7.73%

Post-market: 16.700.00000.00%16:10 EDT

Volume:532.59K

Turnover:8.93M

Market Cap:1.11B

PE:-9.96

High:18.32

Open:18.04

Low:16.25

Close:18.10

52wk High:25.93

52wk Low:16.19

Shares:66.30M

Float Shares:22.12M

Volume Ratio:1.30

T/O Rate:2.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6760

EPS(LYR):-129.2325

ROE:--

ROA:--

PB:-4.01

PE(LYR):-0.13

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Latigo Biotherapeutics Q2 EPS $(27.59) Up From $(36.52) YoY, Sales $0.00, Same YoY

Benzinga Earnings

Latigo Biotherapeutics Posts Q2 FY26 Net Loss of $25.8 Million; G&A Expenses Rise 64.29% to $4.6 Million

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS

Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LTGO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTGO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","market":"US","secType":"STK","nameCN":"Latigo Biotherapeutics Inc","latestPrice":16.7,"timestamp":1790798400000,"preClose":18.1,"halted":0,"volume":532592,"hourTrading":{"tag":"盘后","latestPrice":16.7,"preClose":16.7,"latestTime":"16:10 EDT","volume":288,"amount":4809.599999999999,"timestamp":1790799005651,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07734806629834265,"floatShares":22121291,"shares":66299347,"eps":-1.676,"marketStatus":"Post-Mkt","change":-1.4,"latestTime":"09-30 18:35:17 EDT","open":18.04,"high":18.3199,"low":16.25,"amount":8928131,"amplitude":0.114359,"askPrice":19.14,"askSize":1,"bidPrice":16.7,"bidSize":12,"shortable":0,"etf":0,"ttmEps":-1.676,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":4,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":18.1,"preHourTrading":{"tag":"盘前","latestPrice":18.1,"preClose":18.1,"latestTime":"07:00 EDT","volume":250,"amount":4525,"timestamp":1790766015917,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":16.7,"preClose":16.7,"latestTime":"16:10 EDT","volume":288,"amount":4809.599999999999,"timestamp":1790799005651,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.300135},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","floatShares":22121291,"roa":"--","roe":"--","lyrEps":-129.23255,"volumeRatio":1.300135,"shares":66299347,"dividePrice":0,"high":18.3199,"amplitude":0.114359,"preClose":18.1,"low":16.25,"week52Low":16.19,"pbRate":"-4.01","week52High":25.93,"institutionHeld":0,"latestPrice":16.7,"committee":0.846154,"eps":-1.676,"divideRate":0,"volume":532592,"delay":0,"ttmEps":-1.676,"open":18.04,"prevYearClose":18,"prevWeekClose":17.15,"prevMonthClose":22.02,"prevQuarterClose":18,"fiveDayClose":19.97,"twentyDayClose":22.26,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTGO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTGO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1788580800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTGO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTGO","date":"2026-09-29","current":-10.352029,"percent":0.916667,"low":-14.275436,"twenty":-13.700576,"median":-12.525198,"eighty":-10.986567,"high":-10.230828,"avg":-12.33261,"sd":1.269677,"marketCap":1158912585},"quantilePoints":[{"date":"2026-08-07","current":-10.257227,"twenty":-10.257227,"median":-10.257227,"eighty":-10.257227,"marketCap":1140357438},{"date":"2026-08-14","current":-11.41033,"twenty":-11.020695,"median":-10.545739,"eighty":-10.380784,"marketCap":1268554881},{"date":"2026-08-21","current":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"marketCap":1353293842},{"date":"2026-08-28","current":-14.220252,"twenty":-12.724282,"median":-11.393266,"eighty":-10.557115,"marketCap":1580950750},{"date":"2026-09-04","current":-12.786851,"twenty":-12.786851,"median":-12.172536,"eighty":-10.978035,"marketCap":1421590914},{"date":"2026-09-11","current":-12.849682,"twenty":-13.626145,"median":-12.513822,"eighty":-11.012163,"marketCap":1428087934},{"date":"2026-09-18","current":-14.275436,"twenty":-13.730189,"median":-12.692997,"eighty":-11.073026,"marketCap":1586543373},{"date":"2026-09-25","current":-10.594724,"twenty":-13.725632,"median":-12.593165,"eighty":-11.073026,"marketCap":1177476402},{"date":"2026-09-29","current":-10.42769,"twenty":-13.700576,"median":-12.525198,"eighty":-10.986567,"marketCap":1158912585}],"updateTime":1790777714847},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTGO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664804677","title":"Latigo Biotherapeutics Q2 EPS $(27.59) Up From $(36.52) YoY, Sales $0.00, Same YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804677","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804677?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:04","pubTimestamp":1788469452,"startTime":"0","endTime":"0","summary":"Latigo Biotherapeutics (NASDAQ:LTGO) reported quarterly losses of $(27.59) per share. This is a 24.45 percent increase over losses of $(36.52) per share from the same period last year. The company reported $0.00 in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61617346/latigo-biotherapeutics-q2-eps-27-59-36-52-yoy-sales-0-00-same-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Latigo Biotherapeutics Q2 EPS $(27.59) Up From $(36.52) YoY, Sales $0.00, Same YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664016848","title":"Latigo Biotherapeutics Posts Q2 FY26 Net Loss of $25.8 Million; G&A Expenses Rise 64.29% to $4.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2664016848","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664016848?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:17","pubTimestamp":1788466620,"startTime":"0","endTime":"0","summary":"Latigo Biotherapeutics posts Q2 FY26 net loss of $25.8 million; G&A expenses rise 64.29% to $4.6 millionLatigo posted a net loss of USD 25.8 million for Q2 2026, unchanged from Q2 2025.R&D expense sli","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9C61mB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LTGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809283","title":"Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809283?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA4YKY7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTGO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664432865","title":"Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2664432865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664432865?lang=en_us&edition=fundamental","pubTime":"2026-09-02 02:47","pubTimestamp":1788288420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LTGO/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTGO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LTGO\",params:#limit:6,delay:false,,,undefined,":[]}}